FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:577-578 August 19, 1993 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Manning, W. J. PubMed Citation

To the Editor: In the March 18 issue of the Journal, Manning et al.¹ admirably advocate early cardioversion for atrial fibrillation without prolonged anticoagulation beforehand, if the possibility of atrial thrombi can first be excluded by transesophageal echocardiography. Although we are in full agreement with the concept of a strategy guided by transesophageal echocardiography for the management of anticoagulation and the screening of patients before cardioversion, several issues raised by this study deserve comment.

The study cohort was very heterogeneous with regard to the anticoagulant regimen and the type of cardioversion used. Twenty of the 78 patients (26 percent) who . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Elesber, A. A., Rosales, A. G., Herges, R. M., Shen, W.-K., Moon, B. S., Malouf, J. F., Ammash, N. M., Somers, V., Hodge, D. O., Gersh, B. J., Hammill, S. C., Friedman, P. A. (2006). Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly. Eur Heart J 27: 854-860 [Abstract] [Full Text]